# Jin Li

Source: https://onco.cc/people/li-jin-fuscc/  
OnCo record `li-jin-fuscc` (Person). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

Principal investigator of FRESCO, the Chinese trial that first proved fruquintinib works in refractory colorectal cancer.

## Summary

Jin Li is Professor of Medical Oncology at Fudan University Shanghai Cancer Center and Shanghai East Hospital, specialising in gastrointestinal oncology. He was principal investigator of FRESCO, the Chinese trial that first showed fruquintinib works in previously treated metastatic colorectal cancer, a result later extended internationally in FRESCO-2. He has also led other Chinese gastrointestinal oncology trials, including apatinib in gastric cancer, contributing drugs now used around the world. His publications include the FRESCO randomised trial of fruquintinib against placebo in refractory colorectal cancer.

## Fields

- Kind: Person
- Last checked: 2026-09-08
- Role: Professor of Medical Oncology, Fudan University Shanghai Cancer Center and Shanghai East Hospital; gastrointestinal oncology
- Specialisms: Colorectal cancer; Gastric cancer; Targeted therapy; Clinical trials

## Sources

- Fudan University Shanghai Cancer Center: https://www.shca.org.cn
- PubMed author search: https://pubmed.ncbi.nlm.nih.gov/?term=Li%20J%5BAuthor%5D%20fruquintinib%20FRESCO

## Connected records

- cancers: [Colorectal cancer](https://onco.cc/cancers/colorectal/), [Gastric & gastro-oesophageal junction cancer](https://onco.cc/cancers/gastric/)
- drugs: [Fruquintinib](https://onco.cc/drugs/fruquintinib/)
- institutions: [Chinese Society of Clinical Oncology](https://onco.cc/institutions/csco/), [Fudan University Shanghai Cancer Center](https://onco.cc/institutions/fuscc/)
- trials: [FRESCO-2](https://onco.cc/trials/fresco-2/)

---
JSON: https://onco.cc/api/v1/entities/li-jin-fuscc.json